Example of Reviews in Medical Virology format
Recent searches

Example of Reviews in Medical Virology format Example of Reviews in Medical Virology format Example of Reviews in Medical Virology format Example of Reviews in Medical Virology format Example of Reviews in Medical Virology format Example of Reviews in Medical Virology format Example of Reviews in Medical Virology format Example of Reviews in Medical Virology format Example of Reviews in Medical Virology format Example of Reviews in Medical Virology format Example of Reviews in Medical Virology format Example of Reviews in Medical Virology format Example of Reviews in Medical Virology format Example of Reviews in Medical Virology format Example of Reviews in Medical Virology format Example of Reviews in Medical Virology format Example of Reviews in Medical Virology format Example of Reviews in Medical Virology format Example of Reviews in Medical Virology format
Sample paper formatted on SciSpace - SciSpace
This content is only for preview purposes. The original open access content can be found here.
Look Inside
Example of Reviews in Medical Virology format Example of Reviews in Medical Virology format Example of Reviews in Medical Virology format Example of Reviews in Medical Virology format Example of Reviews in Medical Virology format Example of Reviews in Medical Virology format Example of Reviews in Medical Virology format Example of Reviews in Medical Virology format Example of Reviews in Medical Virology format Example of Reviews in Medical Virology format Example of Reviews in Medical Virology format Example of Reviews in Medical Virology format Example of Reviews in Medical Virology format Example of Reviews in Medical Virology format Example of Reviews in Medical Virology format Example of Reviews in Medical Virology format Example of Reviews in Medical Virology format Example of Reviews in Medical Virology format Example of Reviews in Medical Virology format
Sample paper formatted on SciSpace - SciSpace
This content is only for preview purposes. The original open access content can be found here.
open access Open Access
recommended Recommended

Reviews in Medical Virology — Template for authors

Publisher: Wiley
Categories Rank Trend in last 3 yrs
Infectious Diseases #27 of 288 down down by 7 ranks
Virology #14 of 69 down down by 4 ranks
journal-quality-icon Journal quality:
High
calendar-icon Last 4 years overview: 171 Published Papers | 1517 Citations
indexed-in-icon Indexed in: Scopus
last-updated-icon Last updated: 03/07/2020
Related journals
Insights
General info
Top papers
Popular templates
Get started guide
Why choose from SciSpace
FAQ

Related Journals

open access Open Access

Springer

Quality:  
High
CiteRatio: 6.0
SJR: 2.135
SNIP: 1.267
open access Open Access

Springer

Quality:  
High
CiteRatio: 6.0
SJR: 1.026
SNIP: 1.34
open access Open Access

Elsevier

Quality:  
High
CiteRatio: 5.9
SJR: 1.175
SNIP: 1.033
open access Open Access
recommended Recommended

Elsevier

Quality:  
High
CiteRatio: 23.9
SJR: 4.491
SNIP: 3.727

Journal Performance & Insights

Impact Factor

CiteRatio

Determines the importance of a journal by taking a measure of frequency with which the average article in a journal has been cited in a particular year.

A measure of average citations received per peer-reviewed paper published in the journal.

4.221

14% from 2018

Impact factor for Reviews in Medical Virology from 2016 - 2019
Year Value
2019 4.221
2018 3.702
2017 5.034
2016 5.439
graph view Graph view
table view Table view

8.9

56% from 2019

CiteRatio for Reviews in Medical Virology from 2016 - 2020
Year Value
2020 8.9
2019 5.7
2018 8.0
2017 9.2
2016 9.3
graph view Graph view
table view Table view

insights Insights

  • Impact factor of this journal has increased by 14% in last year.
  • This journal’s impact factor is in the top 10 percentile category.

insights Insights

  • CiteRatio of this journal has increased by 56% in last years.
  • This journal’s CiteRatio is in the top 10 percentile category.

SCImago Journal Rank (SJR)

Source Normalized Impact per Paper (SNIP)

Measures weighted citations received by the journal. Citation weighting depends on the categories and prestige of the citing journal.

Measures actual citations received relative to citations expected for the journal's category.

2.06

37% from 2019

SJR for Reviews in Medical Virology from 2016 - 2020
Year Value
2020 2.06
2019 1.502
2018 1.926
2017 1.957
2016 2.48
graph view Graph view
table view Table view

2.358

87% from 2019

SNIP for Reviews in Medical Virology from 2016 - 2020
Year Value
2020 2.358
2019 1.26
2018 1.607
2017 1.525
2016 1.752
graph view Graph view
table view Table view

insights Insights

  • SJR of this journal has increased by 37% in last years.
  • This journal’s SJR is in the top 10 percentile category.

insights Insights

  • SNIP of this journal has increased by 87% in last years.
  • This journal’s SNIP is in the top 10 percentile category.

Reviews in Medical Virology

Guideline source: View

All company, product and service names used in this website are for identification purposes only. All product names, trademarks and registered trademarks are property of their respective owners.

Use of these names, trademarks and brands does not imply endorsement or affiliation. Disclaimer Notice

Wiley

Reviews in Medical Virology

Virologists are acquisitive investigators who wish to apply the latest scientific developments to their own work. The aim of Reviews in Medical Virology is therefore to provide them with articles reviewing conceptual or technological advances in diverse areas of virology. Topi...... Read More

Infectious Diseases

Virology

Medicine

i
Last updated on
02 Jul 2020
i
ISSN
1052-9276
i
Impact Factor
High - 2.129
i
Open Access
Yes
i
Sherpa RoMEO Archiving Policy
Yellow faq
i
Plagiarism Check
Available via Turnitin
i
Endnote Style
Download Available
i
Bibliography Name
apa
i
Citation Type
Numbered
[25]
i
Bibliography Example
Beenakker, C.W.J. (2006) Specular andreev reflection in graphene.Phys. Rev. Lett., 97 (6), 067 007. URL 10.1103/PhysRevLett.97.067007.

Top papers written in this journal

Journal Article DOI: 10.1002/RMV.535
Review and meta‐analysis of the epidemiology of congenital cytomegalovirus (CMV) infection
Aileen Kenneson1, Michael J. Cannon2

Abstract:

SUMMARY We reviewed studies that reported results of systematic cytomegalovirus (CMV) screening on fetuses and/or liveborn infants. The overall birth prevalence of congenital CMV infection was 0.64%, but varied considerably among different study populations. About 11% of live-born infants with congenital CMV infection were sy... SUMMARY We reviewed studies that reported results of systematic cytomegalovirus (CMV) screening on fetuses and/or liveborn infants. The overall birth prevalence of congenital CMV infection was 0.64%, but varied considerably among different study populations. About 11% of live-born infants with congenital CMV infection were symptomatic, but the inter-study differences in definitions of symptomatic cases limit the interpretation of these data. Non-white race, low socioeconomic status (SES), premature birth, and neonatal intensive care unit admittance were risk factors for congenital CMV infection. Birth prevalence increased with maternal CMV seroprevalence. Maternal seroprevalence accounted for 29% of the variance in birth prevalence between study populations. Maternal seroprevalence and birth prevalence were both higher in study populations that were ascertained at birth rather than in the prenatal period. Thus, timing of ascertainment should be considered when interpreting birth prevalence estimates. Birth prevalence was inversely correlated with mean maternal age, but this relationship was not significant when controlling for maternal seroprevalence. The rate of transmission to infants born to mothers who had a primary infection or a recurrent infection during pregnancy was 32% and 1.4%, respectively. Possible maternal primary infections (i.e. seropositive mother with CMV IgM) resulted in congenital infections about 20% of the time, but are likely to represent a mixture of primary and recurrent infections. In summary, CMV is a common congenital infection worldwide that can lead to permanent disabilities. There is an urgent need for interventions that can reduce the substantial burden of this often overlooked disease. Copyright # 2007 John Wiley & Sons, Ltd. read more read less

Topics:

Premature birth (53%)53% related to the paper, Seroprevalence (51%)51% related to the paper, Pregnancy (51%)51% related to the paper
1,411 Citations
Journal Article DOI: 10.1002/RMV.448
Global distribution of rotavirus serotypes/genotypes and its implication for the development and implementation of an effective rotavirus vaccine.
Norma Santos1, Yasutaka Hoshino2

Abstract:

A safe and effective rotavirus vaccine is urgently needed, particularly in developing countries. Critical to vaccine development and implementation is a knowledge base concerning the epidemiology of rotavirus G and P serotypes/genotypes throughout the world. The temporal and geographical distribution of human rotavirus G and ... A safe and effective rotavirus vaccine is urgently needed, particularly in developing countries. Critical to vaccine development and implementation is a knowledge base concerning the epidemiology of rotavirus G and P serotypes/genotypes throughout the world. The temporal and geographical distribution of human rotavirus G and P types was reviewed by analysing a total of 45571 strains collected globally from 124 studies reported from 52 countries on five continents published between 1989 and 2004. Four common G types (G1, G2, G3 and G4) in conjunction with P[8] or P[4] represented over 88% of the strains analysed worldwide. In addition, serotype G9 viruses associated with P[8] or P[6] were shown to have emerged as the fourth globally important G type with the relative frequency of 4.1%. When the global G and/or P type distributions were divided into five continents/subcontinents, several characteristic features emerged. For example, the P[8]G1 represented over 70% of rotavirus infections in North America, Europe and Australia, but only about 30% of the infections in South America and Asia, and 23% in Africa. In addition, in Africa (i) the relative frequency of G8 was as high as that of the globally common G3 or G4, (ii) P[6] represented almost one-third of all P types identified and (iii) 27% of the infections were associated with rotavirus strains bearing unusual combinations such as P[6]G8 or P[4]G8. Furthermore, in South America, uncommon G5 virus appeared to increase its epidemiological importance among children with diarrhea. Such findings have (i) confirmed the importance of continued active rotavirus strain surveillance in a variety of geographical settings and (ii) provided important considerations for the development and implementation of an effective rotavirus vaccine (e.g. a geographical P-G type adjustment in the formulation of next generation multivalent vaccines). read more read less

Topics:

Rotavirus vaccine (64%)64% related to the paper, Rotavirus (60%)60% related to the paper
1,218 Citations
Journal Article DOI: 10.1002/RMV.655
Review of cytomegalovirus seroprevalence and demographic characteristics associated with infection.
Michael J. Cannon1, D. Scott Schmid1, Terri B. Hyde1

Abstract:

Cytomegalovirus establishes a lifelong latent infection following primary infection that can periodically reactivate with shedding of infectious virus. Primary infection, reactivation and reinfection during pregnancy can all lead to in utero transmission to the developing fetus. Congenital CMV infections are a major cause of ... Cytomegalovirus establishes a lifelong latent infection following primary infection that can periodically reactivate with shedding of infectious virus. Primary infection, reactivation and reinfection during pregnancy can all lead to in utero transmission to the developing fetus. Congenital CMV infections are a major cause of permanent hearing loss and neurological impairment. In this literature review, we found that CMV infection was relatively common among women of reproductive age, with seroprevalence ranging from 45 to 100%. CMV seroprevalence tended to be highest in South America, Africa and Asia and lowest in Western Europe and United States. Within the United States, CMV seroprevalence showed substantial geographic variation as well, differing by as much as 30 percentage points between states, though differences might be explained by variation in the types of populations sampled. Worldwide, seroprevalence among non-whites tended to be 20-30 percentage points higher than that of whites (summary prevalence ratio (PR) = 1.59, 95% confidence interval (CI) = 1.57-1.61). Females generally had higher seroprevalences than males, although in most studies the differences were small (summary PR = 1.13, 95% CI = 1.11-1.14). Persons of lower socioeconomic status were more likely to be CMV seropositive (summary PR = 1.33, 95% CI = 1.32-1.35). Despite high seroprevalences in some populations, a substantial percentage of women of reproductive age are CMV seronegative and thus at risk of primary CMV infection during pregnancy. Future vaccine or educational campaigns to prevent primary infection in pregnant women may need to be tailored to suit the needs of different populations. read more read less

Topics:

Seroprevalence (56%)56% related to the paper
1,207 Citations
Journal Article DOI: 10.1002/RMV.544
New estimates of the prevalence of neurological and sensory sequelae and mortality associated with congenital cytomegalovirus infection.
Sheila C. Dollard1, Scott D. Grosse2, Danielle S. Ross2

Abstract:

Congenital CMV is a major cause of neurological and sensory impairment in children. Reliable estimates of the prevalence of permanent sequelae and mortality associated with congenital CMV are needed to guide development of education and prevention programmes and to gauge the financial costs associated with this disease. To ca... Congenital CMV is a major cause of neurological and sensory impairment in children. Reliable estimates of the prevalence of permanent sequelae and mortality associated with congenital CMV are needed to guide development of education and prevention programmes and to gauge the financial costs associated with this disease. To calculate such estimates, this review used data solely from studies in which children with congenital CMV were identified through universal screening. Based on 15 studies with a total of 117 986 infants screened, the overall CMV birth prevalence estimate was 0.7%. The percentage of infected children with CMV-specific symptoms at birth was 12.7%. The percentage of symptomatic children with permanent sequelae was 40-58%. The percentage of children without symptoms at birth who developed permanent sequelae was estimated to be 13.5%. The true burden of congenital CMV infection is unclear because data on important outcomes, such as visual impairment, are lacking and follow-up of infected children has been too short to fully identify late-onset sequelae. Therefore, the estimates of permanent sequelae associated with congenital CMV presented here are likely underestimates. Future studies should extend follow-up of CMV-infected children identified through universal screening and include the evaluation of visual impairment. read more read less
985 Citations
Journal Article DOI: 10.1002/RMV.384
Hepatitis E virus.
Suzanne U. Emerson1, Robert H. Purcell1

Abstract:

Hepatitis E virus (HEV) is a positive-stranded RNA virus with a 7.2 kb genome that is capped and polyadenylated. The virus is currently unclassified: the organisation of the genome resembles that of the Caliciviridae but sequence analyses suggest it is more closely related to the Togaviridae. Hepatitis E virus is an enterical... Hepatitis E virus (HEV) is a positive-stranded RNA virus with a 7.2 kb genome that is capped and polyadenylated. The virus is currently unclassified: the organisation of the genome resembles that of the Caliciviridae but sequence analyses suggest it is more closely related to the Togaviridae. Hepatitis E virus is an enterically transmitted virus that causes both epidemics and sporadic cases of acute hepatitis in many countries of Asia and Africa but only rarely causes disease in more industrialised countries. Initially the virus was believed to have a limited geographical distribution. However, serological studies suggest that HEV may be endemic also in the United States and Europe even though it infrequently causes overt disease in these countries. Many different animal species worldwide recently have been shown to have antibodies to HEV suggesting that hepatitis E may be zoonotic. Although two related strains have been experimentally transmitted between species, direct transmission from an animal to a human has not been documented. There are four currently recognised genotypes and two of the four contain viruses isolated from swine as well as from humans. Regardless of country of origin or genotype of the virus, most, if not all, strains belong to a single serotype. A promising recombinant vaccine candidate comprised of a truncated capsid protein is currently under evaluation in Nepal. read more read less

Topics:

Hepatitis E virus (70%)70% related to the paper, Hepatitis E (68%)68% related to the paper, Oncovirus (61%)61% related to the paper, Veterinary virology (60%)60% related to the paper, Hepeviridae (60%)60% related to the paper
799 Citations
Author Pic

SciSpace is a very innovative solution to the formatting problem and existing providers, such as Mendeley or Word did not really evolve in recent years.

- Andreas Frutiger, Researcher, ETH Zurich, Institute for Biomedical Engineering

Get MS-Word and LaTeX output to any Journal within seconds
1
Choose a template
Select a template from a library of 40,000+ templates
2
Import a MS-Word file or start fresh
It takes only few seconds to import
3
View and edit your final output
SciSpace will automatically format your output to meet journal guidelines
4
Submit directly or Download
Submit to journal directly or Download in PDF, MS Word or LaTeX

(Before submission check for plagiarism via Turnitin)

clock Less than 3 minutes

What to expect from SciSpace?

Speed and accuracy over MS Word

''

With SciSpace, you do not need a word template for Reviews in Medical Virology.

It automatically formats your research paper to Wiley formatting guidelines and citation style.

You can download a submission ready research paper in pdf, LaTeX and docx formats.

Time comparison

Time taken to format a paper and Compliance with guidelines

Plagiarism Reports via Turnitin

SciSpace has partnered with Turnitin, the leading provider of Plagiarism Check software.

Using this service, researchers can compare submissions against more than 170 million scholarly articles, a database of 70+ billion current and archived web pages. How Turnitin Integration works?

Turnitin Stats
Publisher Logos

Freedom from formatting guidelines

One editor, 100K journal formats – world's largest collection of journal templates

With such a huge verified library, what you need is already there.

publisher-logos

Easy support from all your favorite tools

Reviews in Medical Virology format uses apa citation style.

Automatically format and order your citations and bibliography in a click.

SciSpace allows imports from all reference managers like Mendeley, Zotero, Endnote, Google Scholar etc.

Frequently asked questions

1. Can I write Reviews in Medical Virology in LaTeX?

Absolutely not! Our tool has been designed to help you focus on writing. You can write your entire paper as per the Reviews in Medical Virology guidelines and auto format it.

2. Do you follow the Reviews in Medical Virology guidelines?

Yes, the template is compliant with the Reviews in Medical Virology guidelines. Our experts at SciSpace ensure that. If there are any changes to the journal's guidelines, we'll change our algorithm accordingly.

3. Can I cite my article in multiple styles in Reviews in Medical Virology?

Of course! We support all the top citation styles, such as APA style, MLA style, Vancouver style, Harvard style, and Chicago style. For example, when you write your paper and hit autoformat, our system will automatically update your article as per the Reviews in Medical Virology citation style.

4. Can I use the Reviews in Medical Virology templates for free?

Sign up for our free trial, and you'll be able to use all our features for seven days. You'll see how helpful they are and how inexpensive they are compared to other options, Especially for Reviews in Medical Virology.

5. Can I use a manuscript in Reviews in Medical Virology that I have written in MS Word?

Yes. You can choose the right template, copy-paste the contents from the word document, and click on auto-format. Once you're done, you'll have a publish-ready paper Reviews in Medical Virology that you can download at the end.

6. How long does it usually take you to format my papers in Reviews in Medical Virology?

It only takes a matter of seconds to edit your manuscript. Besides that, our intuitive editor saves you from writing and formatting it in Reviews in Medical Virology.

7. Where can I find the template for the Reviews in Medical Virology?

It is possible to find the Word template for any journal on Google. However, why use a template when you can write your entire manuscript on SciSpace , auto format it as per Reviews in Medical Virology's guidelines and download the same in Word, PDF and LaTeX formats? Give us a try!.

8. Can I reformat my paper to fit the Reviews in Medical Virology's guidelines?

Of course! You can do this using our intuitive editor. It's very easy. If you need help, our support team is always ready to assist you.

9. Reviews in Medical Virology an online tool or is there a desktop version?

SciSpace's Reviews in Medical Virology is currently available as an online tool. We're developing a desktop version, too. You can request (or upvote) any features that you think would be helpful for you and other researchers in the "feature request" section of your account once you've signed up with us.

10. I cannot find my template in your gallery. Can you create it for me like Reviews in Medical Virology?

Sure. You can request any template and we'll have it setup within a few days. You can find the request box in Journal Gallery on the right side bar under the heading, "Couldn't find the format you were looking for like Reviews in Medical Virology?”

11. What is the output that I would get after using Reviews in Medical Virology?

After writing your paper autoformatting in Reviews in Medical Virology, you can download it in multiple formats, viz., PDF, Docx, and LaTeX.

12. Is Reviews in Medical Virology's impact factor high enough that I should try publishing my article there?

To be honest, the answer is no. The impact factor is one of the many elements that determine the quality of a journal. Few of these factors include review board, rejection rates, frequency of inclusion in indexes, and Eigenfactor. You need to assess all these factors before you make your final call.

13. What is Sherpa RoMEO Archiving Policy for Reviews in Medical Virology?

SHERPA/RoMEO Database

We extracted this data from Sherpa Romeo to help researchers understand the access level of this journal in accordance with the Sherpa Romeo Archiving Policy for Reviews in Medical Virology. The table below indicates the level of access a journal has as per Sherpa Romeo's archiving policy.

RoMEO Colour Archiving policy
Green Can archive pre-print and post-print or publisher's version/PDF
Blue Can archive post-print (ie final draft post-refereeing) or publisher's version/PDF
Yellow Can archive pre-print (ie pre-refereeing)
White Archiving not formally supported
FYI:
  1. Pre-prints as being the version of the paper before peer review and
  2. Post-prints as being the version of the paper after peer-review, with revisions having been made.

14. What are the most common citation types In Reviews in Medical Virology?

The 5 most common citation types in order of usage for Reviews in Medical Virology are:.

S. No. Citation Style Type
1. Author Year
2. Numbered
3. Numbered (Superscripted)
4. Author Year (Cited Pages)
5. Footnote

15. How do I submit my article to the Reviews in Medical Virology?

It is possible to find the Word template for any journal on Google. However, why use a template when you can write your entire manuscript on SciSpace , auto format it as per Reviews in Medical Virology's guidelines and download the same in Word, PDF and LaTeX formats? Give us a try!.

16. Can I download Reviews in Medical Virology in Endnote format?

Yes, SciSpace provides this functionality. After signing up, you would need to import your existing references from Word or Bib file to SciSpace. Then SciSpace would allow you to download your references in Reviews in Medical Virology Endnote style according to Elsevier guidelines.

Fast and reliable,
built for complaince.

Instant formatting to 100% publisher guidelines on - SciSpace.

Available only on desktops 🖥

No word template required

Typset automatically formats your research paper to Reviews in Medical Virology formatting guidelines and citation style.

Verifed journal formats

One editor, 100K journal formats.
With the largest collection of verified journal formats, what you need is already there.

Trusted by academicians

I spent hours with MS word for reformatting. It was frustrating - plain and simple. With SciSpace, I can draft my manuscripts and once it is finished I can just submit. In case, I have to submit to another journal it is really just a button click instead of an afternoon of reformatting.

Andreas Frutiger
Researcher & Ex MS Word user
Use this template